The Swedish National Board of Health and Welfare (Socialstyrelsen) has published a report on the costs of dementia in 2012, co-authored by Anders Gustavsson. The costs of dementia are estimated at 63 billion SEK (~7 billion EUR) in 2012, in […]
The article “Survival and clinical metastases among prostate cancer patients treated with androgen deprivation therapy in Sweden” has been published electronically ahead of print in Cancer Epidemiology. Jonas Banefelt and Johan Mesterton of Quantify Research are among the authors of […]
Gylfi Olafsson will be presenting a poster on an economic model of spinal disease at the ISPOR 19th Annual International Meeting, held between May 31st and June 4th in Montreal, Canada.
Fredrik Borgström and Oskar Ström of Quantify Research attended the 2014 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in Seville. For more information on the congress, see here.
2014-01-22
The first Quantify Research Newsletter of 2014 has been published.
2014-01-22
The paper “Economic evaluation of rFVIIa high initial dose compared to rFVIIa standard initial dose in patients with haemophilia with inhibitors using the Czech HemoRec registry”, co-authored by Johan Mesterton, has been published in Thrombosis Research. Pubmed link
The Spine Journal has published the paper “Real-life results of balloon kyphoplasty for vertebral compression fractures from the SWISSspine registry”, of which Quantify Research’s Fredrik Borgström and Gylfi Olafsson are co-authors. Pubmed link
Quantify Research would like to extend a warm welcome to our new CEO Åsa By. A full press release on the appointment of Åsa is available here.
Quantify Research are proud to have welcomed several new colleagues to the team in recent weeks. Introductions to everyone can be found in the Biographies section.
Oskar Ström, Anders Gustavsson and Linda Karlsson of Quantify Research attended the ISPOR 16th Annual European Congress in Dublin. For information on the congress, see here.